SCHEMBL14299205

SCHEMBL14299205

CCO[Si](C#Cc1ccc2ccc3ccccc3c2c1)(OCC)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
CYP1B1 Q16678 2/20 0.46
CYP1A1 P04798 1/20 0.46
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 3/20 0.39
HIF1A Q16665 1/20 0.39
CYP2A6 P11509 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP2D6 P10635 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MAPT P10636 1/20 0.33
HPRT1 P00492 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14299204 0.93 CYP1A2 (0.56) CYP1A2CYP1B1CYP1A1ALDH1A1HSD17B10
SCHEMBL14299207 0.85 CYP1A2 (0.38) CYP1A2CYP1B1CYP1A1ALDH1A1HSD17B10
SCHEMBL3946394 0.77 GRM5 (0.35)
SCHEMBL14299202 0.77 NR1I2 (0.35) CYP1A2CYP1B1CYP1A1ALDH1A1HSD17B10
SCHEMBL21853738 0.77 GRM5 (0.42) ALDH1A1HSD17B10CYP2A6TSHRHPGD
SCHEMBL3947886 0.77 NQO1 (0.33)
SCHEMBL6562820 0.76 APP (0.42) CYP1A2ALDH1A1HSD17B10HPGDKDM4E
SCHEMBL649636 0.75 NQO1 (0.35) CYP1A2ALDH1A1CYP2A6MAPTGAA
SCHEMBL27547748 0.74 CYP1A2 (0.54) CYP1A2CYP1B1CYP1A1ALDH1A1HSD17B10
SCHEMBL30018330 0.73 ALDH1A1 (0.45) CYP1A2CYP1B1CYP1A1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024053-B2 Compound obtained by dimerizing with light irradiation, a compound containing a group having lyophilicity, and a compound containing a group having liquid-repellency JOLED INC. (JP) 2015-05-05 US disclosed
US-8847211-B2 Device, thin film transistor, method for manufacturing the device and method for manufacturing the thin film transistor PANASONIC CORPORATION (JP) 2014-09-30 US disclosed
US-20120330047-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-27 US disclosed
US-20120319090-A1 DEVICE, THIN FILM TRANSISTOR, METHOD FOR MANUFACTURING THE DEVICE AND METHOD FOR MANUFACTURING THE THIN FILM TRANSISTOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120330047-A1 COMPOUND F10, CFD, INF2 CYP1A2 3855/4885CYP1B1 3506/4885CYP1A1 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.